Cargando…

Loss of Rb1 Enhances Glycolytic Metabolism in Kras-Driven Lung Tumors In Vivo

Dysregulated metabolism is a hallmark of cancer cells and is driven in part by specific genetic alterations in various oncogenes or tumor suppressors. The retinoblastoma protein (pRb) is a tumor suppressor that canonically regulates cell cycle progression; however, recent studies have highlighted a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Conroy, Lindsey R., Dougherty, Susan, Kruer, Traci, Metcalf, Stephanie, Lorkiewicz, Pawel, He, Liqing, Yin, Xinmin, Zhang, Xiang, Arumugam, Sengodagounder, Young, Lyndsay E.A., Sun, Ramon C., Clem, Brian F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7016860/ https://www.ncbi.nlm.nih.gov/pubmed/31963621 http://dx.doi.org/10.3390/cancers12010237

Ejemplares similares

Expression of the lncRNA Maternally Expressed Gene 3 (MEG3) Contributes to the Control of Lung Cancer Cell Proliferation by the Rb Pathway
por: Kruer, Traci L., et al.
Publicado: (2016)

Palbociclib treatment alters nucleotide biosynthesis and glutamine dependency in A549 cells
por: Conroy, Lindsey R., et al.
Publicado: (2020)

RB in glutamine metabolism
por: Clem, Brian
Publicado: (2014)

A Novel Small Molecule Antagonist of Choline Kinase-α That Simultaneously Suppresses MAPK and PI3K/AKT Signaling
por: Clem, Brian F., et al.
Publicado: (2011)

Nuclear Pyruvate Kinase M2 (PKM2) Contributes to Phosphoserine Aminotransferase 1 (PSAT1)-Mediated Cell Migration in EGFR-Activated Lung Cancer Cells
por: Biyik-Sit, Rumeysa, et al.
Publicado: (2021)

Rescue of myogenic defects in Rb-deficient cells by inhibition of autophagy or by hypoxia-induced glycolytic shift
por: Ciavarra, Giovanni, et al.
Publicado: (2010)

Integration of flux measurements and pharmacological controls to optimize stable isotope-resolved metabolomics workflows and interpretation
por: Lorkiewicz, Pawel K., et al.
Publicado: (2019)

Targeting aspartate aminotransferase in breast cancer
por: Thornburg, Joshua Marshall, et al.
Publicado: (2008)

Control of Glutamine Metabolism By the Tumor Suppressor Rb
por: Reynolds, Miriam R., et al.
Publicado: (2013)

Senescent melanocytes driven by glycolytic changes are characterized by melanosome transport dysfunction
por: Park, Young Joon, et al.
Publicado: (2023)

Iron out KRAS-driven cancer
por: Lei, Guang, et al.
Publicado: (2022)

To Rb or not to Rb
por: Wells, William A.
Publicado: (2002)

Complete Genome Sequences of T4-Like Bacteriophages RB3, RB5, RB6, RB7, RB9, RB10, RB27, RB33, RB55, RB59, and RB68
por: Yaung, Stephanie J., et al.
Publicado: (2015)

KRAS-driven ROS promote malignant transformation
por: Suh, Yongjoon, et al.
Publicado: (2015)

Twists and turns in Kras-driven tumor initiation
por: Maru, Yoshiaki, et al.
Publicado: (2021)

Clonal dynamics following p53 loss of heterozygosity in Kras-driven cancers
por: Muzumdar, Mandar Deepak, et al.
Publicado: (2016)

Consequences of Zmat3 loss in c-MYC- and mutant KRAS-driven tumorigenesis
por: Best, Sarah A., et al.
Publicado: (2020)

The oncoprotein H-Ras(V12 )increases mitochondrial metabolism
por: Telang, Sucheta, et al.
Publicado: (2007)

Targeting KRAS in Pancreatic Cancer
por: Cowzer, Darren, et al.
Publicado: (2022)

RB depletion is required for the continuous growth of tumors initiated by loss of RB
por: Doan, Alex, et al.
Publicado: (2021)

RB1 loss overrides PARP inhibitor sensitivity driven by RNASEH2B loss in prostate cancer
por: Miao, Chenkui, et al.
Publicado: (2022)

Rewiring glucose metabolism improves 5-FU efficacy in p53-deficient/KRAS(G12D) glycolytic colorectal tumors
por: Ludikhuize, Marlies C., et al.
Publicado: (2022)

Behind the Wheel of Epithelial Plasticity in KRAS-Driven Cancers
por: Arner, Emily N., et al.
Publicado: (2019)

Brown Tumors Belong to the Spectrum of KRAS-driven Neoplasms
por: Turek, Daniel, et al.
Publicado: (2022)

Regional N-glycan and lipid analysis from tissues using MALDI-mass spectrometry imaging
por: Stanback, Alexandra E., et al.
Publicado: (2021)

Histone lactylation driven by mROS-mediated glycolytic shift promotes hypoxic pulmonary hypertension
por: Chen, Jian, et al.
Publicado: (2022)

HIF-1α Is a Metabolic Switch between Glycolytic-Driven Migration and Oxidative Phosphorylation-Driven Immunosuppression of Tregs in Glioblastoma
por: Miska, Jason, et al.
Publicado: (2019)

Keap1 loss promotes Kras-driven lung cancer and results in a dependence on glutaminolysis
por: Romero, Rodrigo, et al.
Publicado: (2017)

Loss of the transcriptional repressor TGIF1 results in enhanced Kras-driven development of pancreatic cancer
por: Weng, Ching-Chieh, et al.
Publicado: (2019)

HK2: a potential regulator of osteoarthritis via glycolytic and non-glycolytic pathways
por: Bao, Chuncha, et al.
Publicado: (2022)

Immunoprevention of KRAS-driven lung adenocarcinoma by a multipeptide vaccine
por: Pan, Jing, et al.
Publicado: (2017)

Targeting copper metabolism to defeat KRAS-driven colorectal cancer
por: Aubert, Léo, et al.
Publicado: (2020)

Small-Molecule Inhibitors and Degraders Targeting KRAS-Driven Cancers
por: Hyun, Soonsil, et al.
Publicado: (2021)

Loss of Rb launches cell cycle
por: Tuma, Rabiya
Publicado: (2003)

Targeting RB1 Loss in Cancers
por: Linn, Paing, et al.
Publicado: (2021)

Coordinate Modulation of Glycolytic Enzymes and OXPHOS by Imatinib in BCR-ABL Driven Chronic Myelogenous Leukemia Cells
por: De Rosa, Viviana, et al.
Publicado: (2019)

PTPN2 regulates the activation of KRAS and plays a critical role in proliferation and survival of KRAS-driven cancer cells
por: Huang, Zhangsen, et al.
Publicado: (2021)

PKM2: A Potential Regulator of Rheumatoid Arthritis via Glycolytic and Non-Glycolytic Pathways
por: Xu, Danyi, et al.
Publicado: (2019)

The beta-decay of $^{95}$Rb and $^{97}$Rb
por: Kratz, K L, et al.
Publicado: (1983)

Synthetic lethality in KRas-driven cancer cells created by glutamine deprivation
por: Mukhopadhyay, Suman, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_accn5gcjqm1b3nh7fnobge6pde